Increased bilirubins and their derivatives in cerebrospinal fluid in Alzheimer's disease

Neurobiology of Aging

Volumn 21, Issue 4, 2000, Pages 551-554

  Kimpara, T ^a,b   Takeda, A ^a   Yamaguchi, T ^c   Arai, H ^a   Okita, N ^d   Takase, S ^d   Sasaki, H ^a   Itoyama, Y ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b National Hospital Organization Sendai Nishitaga Hospital   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d KOHNAN HOSPITAL   (Japan)

Author keywords

Alzheimer's disease; Antioxidant; Bilirubin; Cerebrospinal fluid

Indexed keywords

ANTIOXIDANT; BILIRUBIN; MONOCLONAL ANTIBODY;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BILIRUBIN METABOLISM; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

ADULT; AGED; ALZHEIMER DISEASE; ANTIOXIDANTS; APOLIPOPROTEINS E; BILIRUBIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HUMANS; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 0034622225     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(00)00128-7     Document Type: Article

References (20)

1. Ewing JF, Weber CM, Maines MD. Biliverdin reductase is heat resistant and coexpressed with constitutive and heat shock forms of heme oxygenase in brain. J Neurochem 1993;61:1015-23.
2. Izumi Y., Yamazaki M., Shimizu S., Shimizu K., Yamaguchi T., Nakajima H. Anti-bilirubin monoclonal antibody. II. Enzyme-linked immunosorbent assay for bilirubin fractions by combination of two monoclonal antibodies. Biochimi Biophys Acta. 967:1988;261-266.
3. Kimpara T., Takeda A., Watanabe K., et al. Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. Hum Genet. 100:1997;145-147.
4. Kjellin K.G. Bilirubin compounds in the CSF. J Neurol Sci. 13:1971;161-173.
5. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease . Neurology. 34:1984;939-944.
6. Okumura Y., Yamazaki M., Yamaguchi T., Komoda Y., Sugimoto A., Nakajima H. Anti-bilirubin monoclonal antibody. III. Preparation and properties of monoclonal antibodies to unconjugated bilirubin-IXα Biochi Biophys Acta. 1073:1991;538-542.
7. 14C between blood, cerebrospinal fluid, and brain tissue. Am J Physiol. 221:1971;1264-1270.
8. Schneck M.K., Reisberg B., Ferris S.H. An overview of current concepts of Alzheimer's disease. Am J Psychiatry. 139:1982;165-172.
9. Shibahara S. Heme oxygenase - regulation of and physiological implication in heme catabolism. In:Fujita H., editor. Regulation of heme protein synthesis. Dayton: AlphaMed, 1994. p.103-16.
10. Smith M.A., Kutty R.K., Richey P.L., et al. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol. 145:1994;42-47.
11. Smith MA, Perry G, Sayre LM. A primary role for redox imbalance and oxidative damage in neurodegenerative diseases. Redox regulation of cell signaling and its clinical application. 3rd Internet World Congress on Biomedical Sciences at The Virtual Conference Hall. (http://www.3iwc.riken.go.jp) 1996.
12. Stocker R., Yamamoto Y., McDonagh A.F., Glazer A.N., Ames B.N. Bilirubin is an antioxidant of possible physiological importance. Science. 235:1987;1043-1046.
13. Takahashi M., Sugiyama K., Shumiya S., Nagase S. Penetration of bilirubin into the brain in albumin-deficient and jaundiced rats (AJR) and Nagase analbuminemic rats (NAR). J Biochem. 96:1984;1705-1712.
14. Takeda A., Kimpara T., Onodera H., Itoyama Y., Shibahara S., Kogur K. Regional difference in induction of heme oxygenase-1 protein following rat transient forebrain ischemia. Neurosci Lett. 205:1996;169-172.
15. Takeda A., Onodera H., Sugimoto A., Itoyama Y., Kogure K., Shibahara S. Increased expression of heme oxygenase mRNA in rat brain following transient forebrain ischemia. Brain Res. 666:1994;120-124.
16. Wenham P.R., Price W.H., Blunder G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 337:1991;1158-1159.
17. Yamaguchi T., Hashizume T., Tanaka M., et al. Bilirubin oxidation provoked by endotoxin treatment is suppressed by feeding ascorbic acid in a rat mutant unable to synthesize ascorbic acid. Eur J Biochem. 245:1997;233-240.
18. Yamaguchi T., Shioji I., Sugimoto A., Komoda Y., Nakajima H. Chemical structure of a new family of bile pigments from human urine. J Biochem. 116:1994;298-303.
19. Yamaguchi T., Shioji I., Sugimoto A., Komoda Y., Nakajima H. Epitope of 24G7 anti-bilirubin monoclonal antibody. Biochi Biophys Acta. 1289:1996;110-114.
20. Yamaguchi T., Terakado M., Horio F., Aoki K., Tanaka M., Nakajima H. Role of bilirubin as an antioxidant in an ischemia-reperfusion of rat liver and induction of heme oxygenase. Biochem Biophys Res Commun. 223:1996;129-135.